SKYAID
New 
Mission
Overview   
Details    
Medical   
Watch   
Heart attack  
Stroke    
World health  
Emergency
Cost effective
Media 
- Site Map 

SKYCAR   
Details   
Overview  
VTOL   
Airline   
Military   
Transportation
Images 
- Site Map

Search

Translate 
  8 languages
 

Cost-effectiveness of AED in public places   added 1/26/01

Potential cost-effectiveness of public access defibrillation in the United States.

 Nichol G, Hallstrom AP, Ornato JP, Riegel B, Stiell IG, Valenzuela T, Wells GA, White RD, Weisfeldt ML

 Loeb Medical Research Institute, University of Ottawa, Canada.

 Published in Circulation – 1996?

 BACKGROUND: Approximately 360,000 Americans experience sudden cardiac arrest each year; current treatments are expensive and not very effective. Public access defibrillation (PAD) is a novel treatment for out-of-hospital sudden cardiac arrest that refers to use of automated external defibrillators by the lay public or by nonmedical personnel such as police. A clinical trial has been proposed to evaluate the effectiveness of public access defibrillation, but it is unclear whether such early defibrillation will offer sufficient value for money. Our objective was to estimate the potential cost-effectiveness of public access defibrillation by use of decision analysis.

METHODS AND RESULTS: A decision model compared the potential cost-effectiveness of standard emergency medical services (EMS) systems with that of EMS supplemented by PAD. We considered defibrillation by lay responders or police, using an analysis with a US health-care perspective. Input data were derived from published data or fiscal databases. Future costs and effects were discounted at 3%. Monte Carlo simulation was performed to estimate the variability in the costs and effects of each program. Sensitivity analyses assessed the robustness of the results to changes in input data.

A standard EMS system had a median cost of $5900 per cardiac arrest patient (interquartile range, IQR, $3200 to $10,900) and yielded a median of 0.25 quality-adjusted life years (IQR, 0.20 to 0.30). PAD by lay responders had a median incremental cost of $44,000 per additional quality-adjusted life year (IQR, $29,000 to $68,900). PAD by police had a median incremental cost of $27,200 per additional quality-adjusted life year (IQR, $15,700 to $47,800). The results were sensitive to changes in the cost and relative survival benefit of PAD. CONCLUSIONS: Although more expensive than standard EMS for sudden cardiac arrest, PAD may be economically attractive. The effectiveness and cost-effectiveness of PAD should be assessed in a randomized, controlled trial.

 Skyaid note: Developing countries are “considering” medical improvements which cost $5 per DALY – a similar number